Antibacterial peptide-based gel for prevention of medical implanted-device infection

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Mateescu, Mihaela ^a,b   Baixe, Sébastien ^a,b   Garnier, Tony ^b   Jierry, Loic ^b   Ball, Vincent ^a,b   Haikel, Youssef ^a,b   Metz Boutigue, Marie Hélãne ^a,b   Nardin, Michel ^c   Schaaf, Pierre ^a,b   Etienne, Olivier ^a,b   Lavalle, Philippe ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITÉ DE HAUTE ALSACE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CATECHOL; CATESLYTIN; POLOXAMER; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ALLOY; ANTIMICROBIAL CATIONIC PEPTIDE; BIOMATERIAL; CATECHOL DERIVATIVE; CHROMOGRANIN A; CHROMOGRANIN A (344-358); GLUCURONIC ACID; HEXURONIC ACID; HYDROGEL; PEPTIDE FRAGMENT; POLYMER; TOOTH IMPLANT;

ADHESION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; BIOCOMPATIBILITY; CONTROLLED STUDY; DEVICE INFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDROGEL; NONHUMAN; PORPHYROMONAS GINGIVALIS; PROSTHESIS; TOOTH IMPLANT; CELL ADHESION; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FLOW KINETICS; MICROBIOLOGY;

ALGINATES; ALLOYS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOCOMPATIBLE MATERIALS; CATECHOLS; CELL ADHESION; CELL LINE; CELL SURVIVAL; CHROMOGRANIN A; DENTAL IMPLANTS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGEL; PEPTIDE FRAGMENTS; POLOXAMER; POLYMERS; PORPHYROMONAS GINGIVALIS; RHEOLOGY;

EID: 84955615244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145143     Document Type: Article

References (35)

1. Brandl F, Kastner F, Gschwind RM, Blunk T, Tessmar J, Gopferich A. Hydrogel-based drug delivery systems: Comparison of drug diffusivity and release kinetics. J Control Release. 2010; 142(2):221-8. Epub 2009/11/06. doi: 10.1016/j.jconrel.2009.10.030 PMID: 19887092.
2. Chae JJ, Mulreany DG, Guo Q, Lu Q, Choi JS, Strehin I, et al. Application of a collagen-based membrane and chondroitin sulfate-based hydrogel adhesive for the potential repair of severe ocular surface injuries. Mil Med. 2014; 179(6):686-94. Epub 2014/06/06. doi: 10.7205/milmed-d-13-00360 PMID: 24902138.
3. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention. J Pharm Bioallied Sci. 2015; 7(1):9-14. Epub 2015/02/25. doi: 10.4103/0975-7406.149810 PMID: 25709330; PubMed Central PMCID: PMCPmc4333635.
4. Ding F, Nie Z, Deng H, Xiao L, Du Y, Shi X. Antibacterial hydrogel coating by electrophoretic co-deposition of chitosan/alkynyl chitosan. Carbohydr Polym. 2013; 98(2):1547-52. Epub 2013/09/24. doi: 10. 1016/j.carbpol.2013.07.042 PMID: 24053838.
5. Risbud MV, Hardikar AA, Bhat SV, Bhonde RR. pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J Control Release. 2000; 68(1):23-30. PMID: 10884576
6. Radin S, Ducheyne P, Kamplain T, Tan BH. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. Journal of biomedical materials research. 2001; 57 (2):313-20. Epub 2001/08/03. PMID: 11484196.
7. Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals (Basel). 2014; 7(5):545-94. Epub 2014/05/16. doi: 10.3390/ph7050545 PMID: 24828484; PubMed Central PMCID: PMCPmc4035769.
8. Wang G, Mishra B, Lau K, Lushnikova T, Golla R, Wang X. Antimicrobial peptides in 2014. Pharmaceuticals (Basel). 2015; 8(1):123-50. Epub 2015/03/26. doi: 10.3390/ph8010123 PMID: 25806720; PubMed Central PMCID: PMCPmc4381204.
9. Mahata SK, Mahata M, Wakade AR, O'Connor DT. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): Identification of amino acid residues crucial for activity. Mol Endocrinol. 2000; 14(10):1525-35. Epub 2000/10/24. doi: 10.1210/mend.14.10. 0531 PMID: 11043569.
10. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens. 2002; 20(7):1335-45. Epub 2002/07/20. PMID: 12131530.
11. Kennedy BP, Mahata SK, O'Connor DT, Ziegler MG. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides. 1998; 19(7):1241-8. Epub 1998/10/24. PMID: 9786174.
12. Briolat J, Wu SD, Mahata SK, Gonthier B, Bagnard D, Chasserot-Golaz S, et al. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cellular and molecular life sciences: CMLS. 2005; 62(3):377-85. Epub 2005/02/22. doi: 10.1007/s00018-004-4461-9 PMID: 15723172.
13. Akaddar A, Doderer-Lang C, Marzahn MR, Delalande F, Mousli M, Helle K, et al. Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum. Cellular and molecular life sciences: CMLS. 2010; 67(6):1005-15. Epub 2010/01/01. doi: 10.1007/s00018-009-0235-8 PMID: 20043183; PubMed Central PMCID: PMCPmc2827800.
14. Cado G, Kerdjoudj H, Chassepot A, Lefort M, Benmlih K, Hemmerle J, et al. Polysaccharide films built by simultaneous or alternate spray: A rapid way to engineer biomaterial surfaces. Langmuir: The ACS journal of surfaces and colloids. 2012; 28(22):8470-8. Epub 2012/05/05. doi: 10.1021/la300563s PMID: 22554108.
15. Etienne O, Picart C, Taddei C, Keller P, Hubsch E, Schaaf P, et al. Polyelectrolyte multilayer film coating and stability at the surfaces of oral prosthesis base polymers: An in vitro and in vivo study. J Dent Res. 2006; 85(1):44-8. Epub 2005/12/24. PMID: 16373679.
16. Glinel K, Thebault P, Humblot V, Pradier CM, Jouenne T. Antibacterial surfaces developed from bioinspired approaches. Acta Biomater. 2012; 8(5):1670-84. Epub 2012/02/01. doi: 10.1016/j.actbio. 2012.01.011 PMID: 22289644.
17. Ben-Nissan B, Choi AH. Sol-gel production of bioactive nanocoatings for medical applications. Part 1: An introduction. Nanomedicine (London, England). 2006; 1(3):311-9. Epub 2007/08/25. doi: 10.2217/17435889.1.3.311 PMID: 17716161.
18. Matsuno H, Yudoh K, Hashimoto M, Himeda Y, Miyoshi T, Yoshida K, et al. A new antibacterial carrier of hyaluronic acid gel. J Orthop Sci. 2006; 11(5):497-504. Epub 2006/10/03. doi: 10.1007/s00776-006-1059-0 PMID: 17013739; PubMed Central PMCID: PMCPmc2778615.
19. Johnson DW, Clark C, Isbel NM, Hawley CM, Beller E, Cass A, et al. The honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int. 2009; 29(3):303-9. Epub 2009/05/22. PMID: 19458303.
20. Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. Journal of clinical periodontology. 2008; 35(8 Suppl):286-91. Epub 2008/09/09. doi: 10.1111/j.1600-051X.2008.01274.x PMID: 18724856.
21. Van Winkelhoff AJ. Antibiotics in the treatment of peri-implantitis. European journal of oral implantology. 2012; 5 Suppl:S43-50. Epub 2012/07/28. PMID: 22834393.
22. D'Ercole S, Tete S, Catamo G, Sammartino G, Femminella B, Tripodi D, et al. Microbiological and biochemical effectiveness of an antiseptic gel on the bacterial contamination of the inner space of dental implants: A 3-month human longitudinal study. International journal of immunopathology and pharmacology. 2009; 22(4):1019-26. Epub 2010/01/16. PMID: 20074465.
23. Besimo CE, Guindy JS, Lewetag D, Meyer J. Prevention of bacterial leakage into and from prefabricated screw-retained crowns on implants in vitro. Int J Oral Maxillofac Implants. 1999; 14(5):654-60. Epub 1999/10/26. PMID: 10531737.
24. Nayak AG, Fernandes A, Kulkarni R, Ajantha GS, Lekha K, Nadiger R. Efficacy of antibacterial sealing gel and O-ring to prevent microleakage at the implant abutment interface: An in vitro study. The Journal of oral implantology. 2014; 40(1):11-4. Epub 2011/05/18. doi: 10.1563/aaid-joi-d-10-00167 PMID: 21574837.
25. Paolantonio M, Perinetti G, D'Ercole S, Graziani F, Catamo G, Sammartino G, et al. Internal decontamination of dental implants: An in vivo randomized microbiologic 6-month trial on the effects of a chlorhexidine gel. Journal of periodontology. 2008; 79(8):1419-25. Epub 2008/08/05. doi: 10.1902/jop.2008. 070660 PMID: 18672991.
26. Xu J, Soliman GM, Barralet J, Cerruti M. Mollusk glue inspired mucoadhesives for biomedical applications. Langmuir: The ACS journal of surfaces and colloids. 2012; 28(39):14010-7. Epub 2012/09/07. doi: 10.1021/la3025414 PMID: 22950962.
27. Lee C, Shin J, Lee JS, Byun E, Ryu JH, Um SH, et al. Bioinspired, calcium-free alginate hydrogels with tunable physical and mechanical properties and improved biocompatibility. Biomacromolecules. 2013; 14(6):2004-13. Epub 2013/05/04. doi: 10.1021/bm400352d PMID: 23639096.
28. Ryu JH, Lee Y, Kong WH, Kim TG, Park TG, Lee H. Catechol-functionalized chitosan/pluronic hydrogels for tissue adhesives and hemostatic materials. Biomacromolecules. 2011; 12(7):2653-9. Epub 2011/05/24. doi: 10.1021/bm200464x PMID: 21599012.
29. Kastrup CJ, Nahrendorf M, Figueiredo JL, Lee H, Kambhampati S, Lee T, et al. Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109(52):21444-9. Epub 2012/12/14. doi: 10.1073/pnas. 1217972110 PMID: 23236189; PubMed Central PMCID: PMCPmc3535589.
30. Lee Y, Chung HJ, Yeo S, Ahn C-H, Lee H, Messersmith PB, et al. Thermo-sensitive, injectable, and tissue adhesive sol-gel transition hyaluronic acid/pluronic composite hydrogels prepared from bioinspired catechol-thiol reaction. Soft Matter. 2010; 6(5):977-83.
31. Lin HR, Sung KC, Vong WJ. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine. Biomacromolecules. 2004; 5(6):2358-65. Epub 2004/11/09. doi: 10.1021/bm0496965 PMID: 15530052.
32. Abdullah Al N, Lee H, Lee YS, Lee KD, Park SY. Development of disulfide core-crosslinked pluronic nanoparticles as an effective anticancer-drug-delivery system. Macromolecular bioscience. 2011; 11 (9):1264-71. Epub 2011/07/01. doi: 10.1002/mabi.201100083 PMID: 21717576.
33. Bahar AA, Ren D. Antimicrobial peptides. Pharmaceuticals (Basel). 2013; 6(12):1543-75. Epub 2013/11/30. doi: 10.3390/ph6121543 PMID: 24287494; PubMed Central PMCID: PMCPmc3873676.
34. Pingel LC, Kohlgraf KG, Hansen CJ, Eastman CG, Dietrich DE, Burnell KK, et al. Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunol Cell Biol. 2008; 86(8):643-9. Epub 2008/08/20. doi: 10.1038/icb.2008.56 PMID: 18711400.
35. Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011; 29(9):464-72. Epub 2011/06/18. doi: 10.1016/j.tibtech. 2011.05.001 PMID: 21680034.